This content is from: Home

Deals of the week - September 10 2012

Type of DealValueAcquirerTargetAdviser to acquirer (tax)Adviser to target (tax)
Acquisition$2.6 billionValeant Pharmaceuticals InternationalMedicis Pharmaceutical Sullivan & Cromwell - Ronald Creamer / Skadden, Arps, Meagher & Flom Weil, Gotshal & Manges / Latham & Watkins - Nicholas DeNovio
Acquisition$944.4 millionWeichai PowerKIONHengeler Mueller / King & Wood MallesonsFreshfields Bruckhaus Deringer / Gleiss Lutz
Acquisition$767.8 millionInfra-PSP CanadaGrupo Isolux Corsán Lefosse Advogados / Linklaters
Acquisition$300 millionOTPPManabi Minerais Lefosse Advogados
Acquisition$158.5 millionWarburg PincusEndurance EnergyStikeman Elliott / Willkie Farr & Gallagher
Acquisition$129.8 millionTwin Butte Energy Waseca Energy Stikeman Elliott - Julie D’Avignon
Acquisition$116.8 millionFormFactorAstria Semiconductor Holdings (MicroProbe)Davis Polk & Wardwell - Rachel Kleinberg DLA Piper
Acquisition$95 millionMedaJazz PharmaceuticalsCovington & Burling - Rob Heller
AcquisitionUndisclosedFranchise Services of North AmericaSimply WheelzStikeman Elliott / Edinger Associates / Paul HastingsSidley Austin / Blake, Cassels & Graydon
Type of DealValueIssuer/BorrowerLead managers/arrangersAdviser to issuer/borrower (tax)Adviser to lead managers (tax)
Initial Public Offering$4.2 billionBanco Santander (Grupo Financiero Santander)Barclays / Citigroup / Credit Suisse / Goldman Sachs / JPMorgan / RBC Capital Davis Polk & WardwellShearman & Sterling

The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms and Conditions and Privacy Policy before using the site. All material subject to strictly enforced copyright laws.

© 2021 Euromoney Institutional Investor PLC. For help please see our FAQ.

Instant access to all of our content. Membership Options | One Week Trial

Related